-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Reiterates Buy on Oruka Therapeutics, Maintains $151 Price Target

Benzinga·10/19/2026 09:56:07
BTIG analyst Julian Harrison reiterates Oruka Therapeutics (NASDAQ:ORKA) with a Buy and maintains $151 price target.